[8-K] ORTHOPEDIATRICS CORP Reports Material Event

Rhea-AI Filing Summary

OrthoPediatrics Corp. (KIDS) furnished an investor presentation. The company’s executive officers plan upcoming presentations to investors and analysts and intend to use materials included as Exhibit 99.1, titled “OrthoPediatrics Corp. Investor Presentation” dated October 2025.

The materials are provided under Item 7.01 (Regulation FD) and are furnished, not filed, meaning they are not subject to liability under Section 18 of the Exchange Act and are not incorporated into other Securities Act or Exchange Act filings unless specifically referenced.

0001425450FALSE00014254502023-03-112023-03-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

______________________

Date of Report (Date of earliest event reported): October 28, 2025

OrthoPediatrics Corp.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)

001-38242			26-1761833
(Commission File Number)			(I.R.S. Employer Identification Number)

2850 Frontier Drive Warsaw, Indiana			46582
(Address of principal executive offices)			(Zip Code)

Registrant’s telephone number, including area code: (574) 268-6379

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.00025 par value per share

KIDS

Nasdaq Global Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act (17 CFR 230.405) or Rule 12b-2 under the Exchange Act (17 CFR 240.12b-2).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ¨

Item 7.01. Regulation FD Disclosure.

The executive officers of OrthoPediatrics Corp. have several upcoming presentations to representatives of investors and analysts. The officers intend to use the material filed as Exhibit 99.1 herewith, in whole or in part, as part of those presentations.

The information in this Item 7.01, including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d)			Exhibits
			Exhibit No.			Description
			99.1			Orthopediatrics Corp. Investor Presentation dated October 2025
			104			Cover Page Interactive Data File (embedded within the Inline XBRL document).

* * * * * *

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			OrthoPediatrics Corp.
Date:   October 28, 2025			By:			/s/ Daniel J. Gerritzen
						Daniel J. Gerritzen, General Counsel and Secretary

- 2 -

FAQ

What did OrthoPediatrics (KIDS) announce in this 8-K?

The company furnished an investor presentation as Exhibit 99.1 and noted executives will use it in upcoming investor and analyst meetings.

What is Exhibit 99.1 in the KIDS filing?

Exhibit 99.1 is the OrthoPediatrics Corp. Investor Presentation dated October 2025.

Is the information considered “filed” with the SEC?

No. The information under Item 7.01 (Regulation FD) is furnished, not filed, and is not incorporated into other filings unless specifically referenced.

Does this 8-K include financial results or guidance?

No. It furnishes an investor presentation reference; specific financial data is not included in the excerpt.

Why is Regulation FD noted in the KIDS 8-K?

Regulation FD ensures broad, non-selective disclosure. The company furnished the presentation under Item 7.01 to share information with the market.

Where is OrthoPediatrics’ stock listed and under what symbol?

Common stock trades on the Nasdaq Global Market under the symbol KIDS.